ArticleJMA journal2021

Efficacy and Safety of Low-Dose Pemafibrate Therapy for Hypertriglyceridemia in Patients with Type 2 Diabetes.

Hidenori Bando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.